Skin Fibrosis in SSc Predicts Outcome
(MedPage Today) -- Progressive skin involvement in systemic sclerosis linked with lung deterioration, all-cause death (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 15, 2019 Category: Primary Care Source Type: news
FDA-and-EMA-regulatory-submission-nintedanib-in-SSc-ILD
Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILDSystemic sclerosis (SSc), also known as scleroderma, is a rare chronic connective tissue diseasePulmonary fibrosis, or fibrosing interstitial lung disease (ILD), is a key driver of mortality in people living with SSc and constitutes a high unmet need1,2Improving the lives of people living with pulmonary fibrosis is a key focus for Boehringer Ingelheim (Source: Boehringer Ingelheim Corporate News)
Source: Boehringer Ingelheim Corporate News - March 15, 2019 Category: Research Source Type: news
For Juvenile Scleroderma, Look Beyond the Skin
(MedPage Today) -- Patients can also have joint or CNS disease (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 13, 2019 Category: Dermatology Source Type: news
Scleroderma activist Farah Khaleck: 'I used to be scared looking in the mirror'
Farah Khaleck has a rare and incurable condition which causes the hardening and tightening of her skin. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 3, 2019 Category: Consumer Health News Source Type: news
Economic burden of systemic sclerosis substantial in the US
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 28, 2019 Category: Drugs & Pharmacology Source Type: news
Scleroderma Patients Report Poorer Quality of Life (CME/CE)
(MedPage Today) -- Korean study shows significantly worse health-related QoL versus other rheumatic diseases (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 26, 2019 Category: Primary Care Source Type: news
Inhibiting cancer-causing protein could prevent scleroderma fibrosis
(Michigan Medicine - University of Michigan) Examining the autoimmune disease at the molecular level led researchers to a specific molecule that could be contributing to the disease progression in patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news
Epigenetic Modulation as a Therapy in Systemic Sclerosis Epigenetic Modulation as a Therapy in Systemic Sclerosis
Could epigenetic regulators represent a potential new therapeutic target in systemic sclerosis?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 25, 2019 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Quality of Life Poor in Scleroderma
(MedPage Today) -- Worse than in rheumatoid arthritis or lupus (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 20, 2019 Category: Primary Care Source Type: news
Nurse has tummy fat injected into her face using 'bum lift' technique to combat agonising disease
Amy Daniels, 51, of Wisconsin, suffers with scleroderma, which causes scarring and poor circulation. The mother’s fat was enriched with her own stem cells before being reinjected. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2019 Category: Consumer Health News Source Type: news
Nurse has procedure similar to the Brazilian bum lift to transfer fat from her stomach to her FACE
Amy Daniels, from Wisconsin, suffers with scleroderma, which leaves scarring and poor circulation. The mothers fat was enriched with her own stem cells before being reinjected. (Source: the Mail online | Health)
Source: the Mail online | Health - February 15, 2019 Category: Consumer Health News Source Type: news
The Experience of Raynaud's Phenomenon in Systemic Sclerosis The Experience of Raynaud's Phenomenon in Systemic Sclerosis
A new review explores the patient impact and disease burden of Raynaud ' s phenomenon in systemic sclerosis.Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 4, 2019 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news
Connective tissue on the wrong road -- When organs start to scar
(University of Erlangen-Nuremberg) The increased deposition of connective tissue is a problem in chronic diseases of many organs such as the lungs (idiopathic pulmonary fibrosis), liver (cirrhosis), kidneys (kidney fibrosis), gut (graft versus host disease), and the skin (systemic sclerosis). Up to 40 percent of all deaths in industrial nations are caused by the deposition of connective tissue with subsequent tissue scarring. In spite of this, there are currently very few effective treatments available. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 31, 2019 Category: International Medicine & Public Health Source Type: news
Early Signs for Scleroderma Renal Crisis
(MedPage Today) -- New study lays out range of factors that can increase patients ' risk (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 19, 2019 Category: Primary Care Source Type: news
Angiotensin II receptor blockers
, sometimes called angiotensin II inhibitors, treat a variety of conditions, such as high blood pressure, heart failure and scleroderma. (Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - January 9, 2019 Category: Consumer Health News Source Type: news
